Litigation Details for SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

Docket		Date Filed	2017-09-14
Court	District Court, M.D. North Carolina	Date Terminated	2018-04-24
Cause	28:2201 Declaratory Judgment	Assigned To	Catherine Caldwell Eagles
Jury Demand	Plaintiff	Referred To	Lawrence Patrick Auld
Parties	ALCON LABORATORIES, INC.; ALLERGAN, INC.
Patents	7,351,404; 7,388,029; 7,851,504; 8,038,988; 8,101,161; 8,263,054; 8,278,353; 8,299,118; 8,309,605; 8,338,479; 8,524,777; 8,586,630; 8,772,338; 8,906,962; 8,926,953; 8,933,120; 8,933,127; 9,155,716; 9,241,918; 9,579,270
Attorneys	JONATHAN E. SINGER; ROBERT F. KAPPERS
Firms	Fish & Richardson P.C.; Tharrington Smith, LLP
Link to Docket	External link to docket

Details for SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-09-14	1		infringed U.S. Patent Nos. 7,388,029 (the “’029 patent”) and 7,351,404 (the “’404 patent”). Allergan, …that a new patent number is involved (United States Patent No. 9,579,270 (“the ’270 patent)) and that…infringed U.S. Patent Nos. 8,038,988 (the “’988 patent”), 8,101,161 (the “’161 patent”), and 8,263,054…infringed U.S. Patent Nos. 8,906,962 (the “’962 patent”) and 8,926,953 (the “’953 patent). Allergan, Inc…certain Duke patents, including the ’270 patent asserted in this case as well as the ’029 patent asserted	External link to document
2018-04-24	55		and issues of whether United States Patent 9,579,270 (the ’270 patent) is invalid, unenforceable, or infringed…previously presided over cases that address related patents. This Court’s familiarity with the technical subject…2017 24 April 2018 1:17-cv-00823 830 Patent Plaintiff District Court, M.D. North	External link to document